Background Numerous papers have been published examining risk factors for revision of primary total hip arthroplasty (THA), but there have been no comprehensive systematic literature reviews that ...

"These results suggest that anti-obesity medication use, with relatively safe, effective, and sustainable weight loss, may be ...

When Jennie Garth announced she'd had not one but two hip replacements-the first at age 48 and the second in 2024 at 52-the ...

Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care for patients, is announcing the Food ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement. HealthDay News — For patients with obesity undergoing joint replacement ...

Obesity is a major risk factor for joint failure because excess weight puts more stress on the implants, leading to ...

An 18% to 47% lower risk among hip replacement patients ... Postoperative Weight Loss After Antiobesity Medications and ...

"Greater weight loss within a year of starting anti-obesity medications was linked to a lower risk of joint replacement ...

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 ...

For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications ...